Intense Competition: Veeva operates in a highly competitive market against established enterprise software vendors and specialized industry players, which could impact market share, pricing, and growth opportunities.

Concentration in Life Sciences Industry: The company's significant reliance on the life sciences sector exposes it to industry-specific risks, including economic downturns, changes in regulatory environments, or shifts in customer spending patterns unique to pharmaceuticals and biotechnology.

Data Security and Privacy Risks: Handling sensitive customer and patient data across various global jurisdictions necessitates robust data security measures and compliance with complex privacy regulations (e.g., GDPR, HIPAA), with any breach or non-compliance posing significant reputational and financial harm.